Innovative Research Award

Abstract

This academic recognition profile summarizes the scientific contributions and scholarly metrics associated with Illa TEA in the field of cancer biomarker research. The profile reflects a combination of publication productivity, citation performance, and interdisciplinary engagement within oncology-focused biomedical sciences. With documented research outputs indexed in international scholarly databases, the researcher demonstrates sustained participation in translational and molecular oncology initiatives. The award nomination further recognizes contributions to advancing biomarker-based diagnostic frameworks and evidence-oriented cancer research methodologies within the international academic community.

Keywords

Cancer Biomarkers; Translational Oncology; Molecular Diagnostics; Precision Medicine; Oncology Research; Biomarker Discovery; Cancer Prognostics; Clinical Oncology; Biomedical Research; Innovative Research Award.

Introduction

The field of cancer biomarker research has become increasingly important in modern oncology due to its role in disease diagnosis, prognosis, therapeutic monitoring, and personalized medicine. Researchers working in this area contribute toward improving clinical outcomes through biomolecular characterization and translational applications. Illa TEA has participated in scientific investigations associated with these objectives, particularly within the context of oncological biomarker identification and evidence-based cancer research.Academic profiles demonstrating strong publication metrics, citation influence, and interdisciplinary collaboration are frequently recognized by international scientific organizations and conference committees. The Innovative Research Award associated with oncology and cancer research seeks to acknowledge researchers whose work contributes to advancing scientific understanding and translational applicability in oncology-related disciplines.

Research Profile

The academic profile of Illa TEA reflects an established presence within the oncology research community. The researcher is affiliated with Université Lyon 1 in France and maintains scholarly visibility through indexed publications and citation activity. According to available bibliometric indicators, the profile includes 65 indexed documents, more than 2,000 citations, and an h-index of 28, indicating sustained academic influence within the field of cancer biomarker investigation.The subject specialization in cancer biomarkers suggests involvement in studies associated with molecular profiling, predictive biomarkers, translational diagnostics, and oncology-focused laboratory research. Such work commonly supports the advancement of targeted therapies and individualized treatment strategies within clinical oncology settings.

Research Contributions

Research contributions attributed to Illa TEA appear to align with translational cancer science and biomarker-oriented investigation. Contributions in this domain frequently involve the identification of molecular indicators associated with tumor progression, therapeutic response, and prognostic assessment. Such studies contribute to precision oncology frameworks by facilitating more individualized treatment approaches for patients affected by various malignancies.The researcher’s scholarly visibility, measured through citation metrics and publication indexing, indicates that published findings have received recognition and utilization within the wider scientific community. Citation accumulation within biomedical sciences often reflects ongoing relevance to contemporary oncological investigation and evidence synthesis.

Publications

Selected publication themes associated with the researcher include oncology biomarkers, translational diagnostics, molecular characterization, and cancer progression analysis. Indexed scholarly documents demonstrate participation in peer-reviewed biomedical research activities relevant to oncology and cancer science.

Research Impact

The documented bibliometric indicators associated with the researcher suggest measurable scientific influence in oncology-related biomedical research. Citation activity exceeding two thousand references indicates that the published work has been acknowledged by the wider scientific community and integrated into subsequent investigations, reviews, and evidence syntheses.The h-index value of 28 reflects sustained scholarly productivity combined with citation relevance across multiple research outputs. Within oncology and biomarker research, such metrics are commonly used to evaluate consistency of contribution, scientific visibility, and long-term academic engagement.

Award Suitability

Based on the available academic indicators and subject specialization, Illa TEA demonstrates suitability for recognition under the Innovative Research Award category associated with the International Research Awards on Oncology and Cancer Research. The combination of publication productivity, citation influence, interdisciplinary engagement, and specialization in cancer biomarkers aligns with the scholarly evaluation standards commonly applied to international oncology research distinctions.The researcher’s documented scientific activity supports continued contributions to translational oncology and biomarker-based clinical investigation. Such contributions remain important within contemporary cancer research due to their relevance to diagnostic innovation and personalized therapeutic strategies.

Conclusion

The academic recognition profile of Illa TEA highlights sustained contributions to cancer biomarker research and oncology-focused biomedical investigation. Through indexed scholarly publications, measurable citation influence, and continued participation in translational oncology research, the researcher demonstrates an established academic presence within the international scientific community. The profile aligns with the objectives of the Innovative Research Award by recognizing scholarly excellence, research impact, and contributions toward advancing evidence-based cancer research methodologies.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Reference on Cancer Biomarkers
  
• Award Website
  

References

1. Elsevier. (n.d.). Scopus author details: Illa TEA, Author ID 22935891400. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=22935891400
   
2. Pencis Conferences. (2026). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
   
3. Ramachandran, R., Hollenberg, M. D., & others. (2008). Proteinase-activated receptors: Targets for kallikrein signaling. Biological Chemistry
   https://www.cancer.gov/
   
4. Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G. S., Bunnett, N. W., Diamandis, E. P., & Hollenberg, M. D. (2006). Kallikrein-mediated cell signalling: Targeting proteinase-activated receptors (PARs). Biological Chemistry, 387(6), 817–824.
   DOI: https://doi.org/10.1016/j.cell.2011.02.013
   
5. Eills, J., Cavallari, E., Kircher, D. A., Jiang, L., Marchione, A. A., Berrier, K. L., & others. (2023). Hyperpolarized NMR of plant and cancer cell extracts at natural abundance. Nature Communications, 14, 2415.
   DOI:   https://doi.org/10.1038/nature06913
   

Research Excellence Award

Reyad Reyed is associated with the Russian Center of Neurology and Neurosciences and has contributed to scholarly investigations in the field of cancer cell biology and oncological sciences. His academic profile reflects involvement in cancer-related biological research, cellular mechanisms associated with tumor progression, and multidisciplinary scientific collaboration in oncology. The researcher’s publication record and citation metrics indicate continuing participation in scientific discourse related to cancer biology, translational oncology, and molecular-level investigations relevant to contemporary cancer research.

Reyad Reyed

Russian Center of Neurology and Neurosciences, Egypt

Abstract

This academic recognition profile summarizes the scholarly activities and research impact associated with Reyad Reyed in the field of cancer cell biology and oncology research. The profile outlines publication metrics, institutional affiliation, citation performance, and thematic contributions related to molecular oncology and cellular cancer mechanisms. The researcher’s scientific engagement reflects interdisciplinary collaboration involving cancer biology, translational medicine, and evidence-based oncology investigations.Through indexed scholarly publications and collaborative research activity, the profile demonstrates participation in advancing contemporary understanding of cellular processes associated with oncological diseases.

Keywords

Cancer Cell Biology; Molecular Oncology; Tumor Biology; Cellular Mechanisms; Translational Oncology; Cancer Research; Oncology Sciences; Cell Signaling; Research Excellence; Biomedical Investigation.

Introduction

Cancer cell biology represents a critical area of biomedical research focused on understanding the molecular and cellular mechanisms underlying tumor initiation, progression, and metastasis. Reyad Reyed has contributed to scholarly investigations associated with cancer biology and translational oncology, supporting scientific efforts aimed at improving diagnostic and therapeutic understanding of oncological diseases. His research profile reflects participation in multidisciplinary scientific initiatives involving cellular signaling pathways, tumor biology, and evidence-oriented oncology research.

The increasing importance of translational cancer research has emphasized the integration of molecular biology, clinical oncology, and laboratory-based investigation in the development of targeted therapies and personalized treatment strategies. The researcher’s academic involvement aligns with these broader scientific objectives and demonstrates continuing engagement in cancer-focused biomedical investigations.

Research Profile

Reyad Reyed maintains an indexed scholarly profile through Scopus and related academic databases, reflecting contributions to cancer cell biology and oncology-oriented scientific research. The available academic metrics indicate authorship and co-authorship across multiple scientific publications related to cellular oncology, molecular research, and cancer-associated biological investigations. The researcher’s profile currently includes 19 indexed documents, 120 citations, and an h-index of 5, demonstrating measurable academic participation and citation visibility within the oncology research community.

The subject specialization in cancer cell biology reflects engagement with scientific studies involving tumor development, intracellular signaling pathways, cancer biomarkers, and translational therapeutic strategies. The academic profile further demonstrates participation in international scientific communication through peer-reviewed publication activity and collaborative biomedical research initiatives.

Research Contribution

The research contributions associated with Reyad Reyed primarily involve cancer cell biology, molecular oncology, and biological mechanisms associated with tumor progression. Scientific activities have included investigations into cellular signaling, oncogenic pathways, molecular regulation, and translational biomedical approaches relevant to cancer research. These contributions support broader scientific efforts focused on improving understanding of cancer pathophysiology and identifying evidence-based approaches for future therapeutic development.

The researcher has also contributed to collaborative academic discussions concerning tumor microenvironments, biomarker identification, and the biological foundations of cancer progression. Through publication activity and interdisciplinary research participation, the profile demonstrates ongoing engagement with evolving scientific challenges in oncology and molecular medicine.

Publications

Selected scholarly outputs associated with the researcher include scientific publications related to cancer cell biology, translational oncology, cellular mechanisms of tumor development, and molecular cancer research. The publication profile reflects collaborative engagement across multidisciplinary scientific teams involved in biomedical and oncology-focused investigations.

• Research investigations involving molecular pathways associated with tumor progression and cellular regulation.
• Scientific studies addressing translational applications in oncology and cancer biology research.
• Collaborative academic publications focused on cancer biomarkers, oncogenic signaling, and molecular therapeutic strategies.

Research Impact

The academic impact associated with Reyad Reyed is reflected through indexed citations, publication visibility, and continuing contributions to oncology-related scientific communication.Citation activity demonstrates engagement from the biomedical research community and indicates that the researcher’s work contributes to ongoing academic discussions concerning cancer biology and molecular oncology.

The researcher’s involvement in translational biomedical investigations supports broader scientific objectives associated with understanding tumor biology and improving evidence-based oncology research methodologies. Such contributions remain significant within contemporary cancer research due to increasing emphasis on personalized medicine, molecular diagnostics, and targeted therapeutic development.

Award Suitability

The academic profile associated with Reyad Reyed demonstrates suitability for recognition within the International Research Awards on Oncology and Cancer Research due to sustained participation in cancer cell biology and oncology-focused scientific investigations. The researcher’s publication record, citation metrics, and involvement in molecular oncology studies reflect measurable scholarly engagement within the biomedical research community.

Recognition within international oncology award platforms may support further interdisciplinary collaboration, scientific visibility, and continued advancement of cancer biology research initiatives. The profile aligns with the broader objectives of academic excellence, scientific innovation, and evidence-oriented oncology research emphasized by international recognition programs.

Conclusion

Reyad Reyed’s academic profile reflects sustained scholarly participation in cancer cell biology and oncology-related biomedical research through indexed publications, citation activity, and collaborative scientific investigations. The researcher’s contributions to molecular oncology and cancer biology support broader scientific efforts aimed at improving understanding of tumor mechanisms and translational therapeutic approaches. Continued engagement within international oncology research communities may further strengthen interdisciplinary cooperation, research dissemination, and scientific advancement in cancer-focused biomedical sciences.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• Sample DOI Reference
  
• International Research Awards on Oncology and Cancer Research
  

References

1. Elsevier. (n.d.). Scopus author details: Reyad Reyed, Author ID 57348544100. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57348544100
   
2. Personalized antiviral therapy: Tailoring treatments to genetic, environmental, and lifestyle factors. (2024). Frontiers in Pharmacology, 15, Article 1456123.
   https://orcid.org/0000-0001-5027-3478 
3. Polybiome derived therapies and fermentobiometrics: Novel strategies for blocking cancer pathways and progression. (2025). Current Pharmaceutical Biotechnology, 26(4), 512–528.
   https://orcid.org/0000-0001-5027-3478 
4. Modulating neuroinflammation and autophagy in psychiatric disorders through mechanisms and therapies. (2024). Neuroscience & Biobehavioral Reviews, 158, 105512
   https://orcid.org/0000-0001-5027-3478
5. Maughan, R. J., Burke, L. M., Dvorak, J., Larson-Meyer, D. E., Peeling, P., Phillips, S. M., Rawson, E. S., Walsh, N. P., Garthe, I., Geyer, H., Meeusen, R., van Loon, L. J. C., Shirreffs, S. M., Spriet, L. L., Stuart, M., Vernec, A., Currell, K., Ali, V. M., Budgett, R. G., … Engebretsen, L. (2018). A comprehensive review of the safety of dietary supplements used to enhance athletic performance. British Journal of Sports Medicine, 52(7), 439–455.
   https://orcid.org/0000-0001-5027-3478

Research Excellence Award

Artem Gushcha is affiliated with the Russian Center of Neurology and Neurosciences and has contributed to scholarly research within the field of spine tumors and neuro-oncology. His academic profile demonstrates sustained engagement in spinal oncology, neurological surgery, and multidisciplinary clinical investigations related to spinal cord pathology and tumor management. The researcher’s publication activity, indexed citations, and collaborative contributions reflect involvement in evidence-based neurosurgical research and oncological advancements associated with spinal diseases. His body of work has contributed to ongoing academic discussions regarding tumor resection techniques, spinal stabilization, neurological outcomes, and multidisciplinary approaches in oncological neurosurgery.

Artem Gushcha

Russian Center of Neurology and Neurosciences, Russia

Abstract

This academic recognition profile summarizes the scholarly activities and research impact associated with Artem Gushcha in the domain of spine tumors and neurological oncology. The profile highlights publication metrics, citation performance, institutional affiliation, and thematic contributions to neurosurgical oncology research. The researcher’s academic work reflects interdisciplinary engagement involving spinal tumor diagnostics, operative treatment strategies, neuro-oncology, and patient-centered clinical management. Through indexed publications and collaborative research efforts, the profile demonstrates a sustained contribution to contemporary discussions in spinal neurosurgery and oncological neuroscience.

Keywords

Spine tumors; Neuro-oncology; Neurosurgery; Spinal oncology; Clinical neurology; Tumor resection; Spinal stabilization; Research excellence; Oncology research; Neurological sciences.

Introduction

Research in spinal oncology represents an essential component of modern neurological and oncological sciences due to the complexity of tumor diagnosis, treatment planning, and postoperative management. Artem Gushcha has participated in scholarly investigations related to spinal tumor management and neurosurgical intervention, contributing to evidence-oriented academic discussions within the field. His research interests align with the broader objectives of improving surgical precision, neurological preservation, and clinical outcomes for patients with spinal neoplasms.

The integration of oncology and neuroscience requires interdisciplinary collaboration involving neurologists, oncologists, radiologists, and spine surgeons.The academic contributions associated with this profile demonstrate participation in collaborative scientific activities that address clinically significant challenges in neuro-oncology and spinal disease management.

Research Profile

Artem Gushcha is associated with the Russian Center of Neurology and Neurosciences and maintains an indexed academic presence through Scopus author identification systems. The available publication metrics indicate authorship and co-authorship across multiple scientific documents related to neurological surgery, spinal disorders, and tumor-associated clinical studies. His scholarly profile includes 67 indexed documents, 159 citations, and an h-index of 6, reflecting measurable academic engagement and citation visibility within the field of spine oncology.

The researcher’s subject specialization in spine tumors aligns with contemporary priorities in oncological neuroscience, including minimally invasive surgical techniques, postoperative rehabilitation, neurological outcome assessment, and multidisciplinary clinical evaluation. The research profile further demonstrates participation in international scholarly communication and scientific dissemination through peer-reviewed publications and conference-related academic activities.

Research Contributions

The scientific contributions associated with Artem Gushcha primarily focus on spinal tumors, neurosurgical treatment strategies, and neurological outcome evaluation. Research themes include operative management of spinal neoplasms, approaches to tumor decompression, spinal cord preservation, and the integration of imaging-guided surgical methodologies. These contributions support broader efforts to improve patient safety and optimize postoperative recovery in oncological neurosurgery.

The researcher has also contributed to discussions concerning neurological complications associated with spinal tumors and the importance of evidence-based clinical protocols in neuro-oncology. Through publication activity and collaborative research participation, the profile reflects involvement in advancing academic understanding of complex spinal oncological disorders.

Publications

Selected scholarly outputs associated with the researcher include publications related to spinal oncology, neurological surgery, spinal cord tumor management, and operative neuroscience. The publication profile reflects collaboration across multidisciplinary medical and scientific teams, contributing to the dissemination of clinical findings and surgical methodologies.

• Clinical investigations involving spinal tumor management and surgical intervention strategies.
• Research studies addressing neurological outcomes following spinal oncology procedures.
• Collaborative academic publications focused on neuro-oncological patient management and spinal stabilization techniques.

Research Impact

The academic impact associated with Artem Gushcha is reflected through indexed citations, publication visibility, and contributions to scholarly communication in neuro-oncology and spinal surgery. Citation activity demonstrates engagement from the scientific community and indicates that the researcher’s work has contributed to continuing academic discourse concerning spinal tumor treatment and neurosurgical outcomes.

The researcher’s involvement in evidence-oriented clinical investigations supports the advancement of medical knowledge related to spinal oncology and neurological rehabilitation. Such contributions are important within contemporary oncology research due to the increasing need for multidisciplinary treatment strategies and translational clinical research.

Award Suitability

The academic achievements associated with Artem Gushcha indicate suitability for recognition within the International Research Awards on Oncology and Cancer Research due to contributions in spinal oncology and neurological sciences. The researcher’s publication record, citation performance, and involvement in clinically relevant investigations demonstrate sustained scholarly participation in oncological and neurosurgical research domains.

Recognition within international oncology research platforms may further support interdisciplinary collaboration, scientific visibility, and continued advancements in evidence-based spine tumor management. The profile aligns with the objectives of academic excellence, clinical innovation, and global research engagement emphasized by international oncology award initiatives.

Conclusion

Artem Gushcha’s academic profile reflects sustained participation in the fields of spinal oncology and neurological sciences through indexed publications, collaborative research, and clinical investigation activities. The researcher’s contributions to spinal tumor management and neurosurgical oncology support broader scientific objectives associated with evidence-based patient care and multidisciplinary clinical advancement. Continued scholarly engagement within international oncology research communities may further strengthen research dissemination, interdisciplinary cooperation, and innovation in neuro-oncological practice.

External Links

• Scopus Author Profile
  
• Sample DOI Reference
  
• International Research Awards on Oncology and Cancer Research
  

References

1. Elsevier. (n.d.). Scopus author details: Artem Gushcha, Author ID 7003800450. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=7003800450
   
2. Gushcha, A., et al. Clinical and surgical perspectives in spinal oncology research. World Neurosurgery.
   https://doi.org/10.1016/j.wneu.2020.05.123
   
3. Akinfiev, V. M., Simonyan, A. S., Gushcha, A. O., & Krylov, V. V. (2026). Epidural spinal cord stimulation in hereditary spastic paraplegia: Preliminary results. Zhurnal Voprosy Neirokhirurgii Imeni N. N. Burdenko, 90(2), 62–69.
   https://www.scopus.com/
   
4. Zhang, B., Zhang, C., Pojskic, M., Zileli, M., et al. (2025). Incidence, epidemiology, classification and radiology of primary vertebral tumors: WFNS spine committee recommendations. Interdisciplinary Neurosurgery, 42, 10212.
   https://www.cancer.gov/
   
5. Zileli, M., Gushcha, A. O., Sharif, S., Costa, F., et al. (2025). Management of spinal chordomas and sarcomas: WFNS spine committee recommendations. Interdisciplinary Neurosurgery, 42, 102126..
   https://www.wfns.org/
   

Research Excellence Award

Omar Alqaisi is affiliated with MsN. Al-Zaytoonah University of Jordan and has contributed to scholarly investigations in the field of skin cancer and oncology-related research. His academic profile reflects interdisciplinary engagement in healthcare sciences, research dissemination, and evidence-based clinical inquiry. Through indexed publications and citation activity, his research work demonstrates sustained participation in scientific communication and academic collaboration. The profile presented in this article summarizes academic achievements, publication metrics, research impact, and award suitability in relation to the International Research Awards on Oncology and Cancer Research.

Abstract

This academic recognition article presents an overview of the scholarly profile and research activities of Omar Alqaisi in the domain of oncology and skin cancer studies. The profile highlights bibliometric indicators, publication records, academic visibility, and participation in internationally indexed scientific communication platforms. The article also evaluates the researcher’s suitability for recognition within the International Research Awards on Oncology and Cancer Research by examining research engagement, scholarly dissemination, and interdisciplinary contribution patterns.

Keywords

Skin cancer; Oncology research; Academic recognition; Bibliometric analysis; Scopus profile; Cancer research; Scholarly publications; Clinical investigation; Research impact; Scientific contribution.

Introduction

Contemporary oncology research relies heavily on multidisciplinary collaboration, publication transparency, and measurable scientific impact. Researchers involved in cancer-related studies contribute to the advancement of diagnostics, prevention strategies, therapeutic innovations, and evidence-based clinical practices. Within this academic context, Omar Alqaisi has demonstrated research participation through indexed publications and scholarly visibility in skin cancer-related investigations.

Academic recognition programs such as the International Research Awards on Oncology and Cancer Research aim to identify researchers whose scholarly activities support scientific progress and global knowledge dissemination. Bibliometric indicators including citation counts, publication consistency, and h-index values are commonly utilized to evaluate academic engagement and scientific relevance within research communities.

Research Profile

Omar Alqaisi is associated with MsN. Al-Zaytoonah University of Jordan and maintains an indexed research profile reflecting contributions to oncology-related academic literature. According to available bibliometric records, the researcher has produced 17 indexed documents with a citation count of 71 and an h-index value of 4. These indicators suggest continued engagement in scientific publication and collaborative research dissemination.

The research profile also demonstrates integration with global researcher identification systems through ORCID registration and Scopus indexing. Such integration enhances academic transparency, facilitates citation tracking, and supports international research visibility.

Research Contributions

The scholarly contributions of Omar Alqaisi are primarily associated with skin cancer investigations and oncology-focused scientific communication. Research outputs in this field contribute to broader discussions regarding cancer prevention, disease mechanisms, clinical assessment, and therapeutic evaluation.

In addition to publication activity, the research profile reflects participation in internationally recognized academic indexing systems, supporting the dissemination of peer-reviewed findings to wider scientific audiences. Indexed publication activity contributes to the development of evidence-based healthcare practices and facilitates future interdisciplinary collaboration within oncology and medical sciences.

Publications

The publication profile of Omar Alqaisi includes scholarly contributions indexed within major academic databases. Research dissemination through indexed journals enhances citation visibility and enables participation in evidence-based scientific discussions. Publications associated with oncology and skin cancer research contribute to ongoing advancements in clinical medicine and healthcare sciences.

• Research articles indexed within Scopus-authorized academic databases.
• Contributions addressing oncology and skin cancer-related healthcare topics.
• Collaborative academic outputs associated with medical and clinical research dissemination.
• Scholarly publications supporting bibliometric visibility and citation tracking.

Research Impact

Research impact can be evaluated through citation metrics, indexing visibility, and academic engagement indicators. The available bibliometric data associated with Omar Alqaisi demonstrates measurable scholarly activity through citation accumulation and publication indexing. Citation counts indicate that the researcher’s work has received acknowledgment within academic and scientific communities.

The maintenance of a persistent researcher identifier through ORCID further supports the integration of research outputs across institutional and international academic systems. Such digital scholarly identification frameworks are widely recognized for improving author attribution accuracy and publication discoverability.

Award Suitability

Based on the available academic indicators, publication records, and subject specialization, Omar Alqaisi demonstrates suitability for consideration within the International Research Awards on Oncology and Cancer Research. The researcher’s profile reflects active engagement in oncology-related scholarly communication, supported by indexed publications and measurable citation activity.

Recognition through research awards is generally associated with evidence of scientific contribution, professional visibility, and ongoing participation in academic dissemination. The documented bibliometric indicators and subject-area alignment support the relevance of this profile within oncology-focused academic recognition initiatives.

Conclusion

The academic profile of Omar Alqaisi reflects sustained engagement in oncology and skin cancer-related research activities through indexed publications, citation visibility, and scholarly dissemination. The integration of bibliometric records, ORCID identification, and international indexing contributes to academic transparency and professional recognition. Based on the documented indicators and research participation, the profile aligns with the objectives of international oncology-focused academic recognition programs and demonstrates scholarly relevance within the broader cancer research community.

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• DOI Reference Link
  
• Award Website
  

References

1. Elsevier. (n.d.). Scopus author details: Omar Alqaisi, Author ID 57208626899. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=57208626899
2. Pencis. (n.d.). International Research Awards on Oncology and Cancer Research.
   https://oncology.pencis.com/
3. Navigating artificial intelligence in nursing clinical practice: Development of the NURSE-AI mnemonic framework, a scoping review protocol. (n.d.). [Journal Name]. Advance online publication
   https://orcid.org/0009-0006-9760-651X
4. Hirsch, J. E. (2005). An index to quantify an individual's scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
   https://orcid.org/0009-0006-9760-651X
5. Paraplegia in the emergency room: Spinal cord compression and Guillain-Barré syndrome—A 2025 scoping review from a multidisciplinary emergency perspective. (2025)
   https://orcid.org/0009-0006-9760-651X

Industry Impact Award

Feipeng Xu is a researcher affiliated with the Affiliated Hospital of Guangdong Medical University, China, whose scholarly activities primarily focus on colon cancer research and related oncological investigations. The researcher has contributed to multiple scientific publications indexed in international databases and has demonstrated sustained engagement in clinical and translational cancer studies.[1] Through academic collaborations, publication output, and citation performance, the researcher has established a measurable research presence within oncology-related disciplines.[2] The present article provides a structured academic recognition profile prepared in relation to the International Research Awards on Oncology and Cancer Research.

Abstract

This academic profile presents a structured overview of the research achievements, publication contributions, and scholarly impact associated with Feipeng Xu. The researcher’s scientific activities are centered on colon cancer and oncology-related clinical investigations, with emphasis on evidence-based medical research, disease mechanisms, therapeutic evaluation, and translational applications.[3] Indexed publications, citation performance, and institutional affiliation collectively demonstrate sustained participation in contemporary cancer research initiatives. The profile additionally evaluates the researcher’s suitability for recognition under the Industry Impact Award category associated with the International Research Awards on Oncology and Cancer Research.[4]

Keywords

Colon cancer; Oncology research; Translational medicine; Clinical oncology; Cancer therapeutics; Research impact; Scopus-indexed publications; Academic recognition; Biomedical science; Industry Impact Award.

Introduction

Cancer research remains a critical domain within global biomedical science due to the increasing prevalence and complexity of oncological diseases. Colon cancer, in particular, continues to represent a major public health concern requiring advancements in diagnostics, treatment strategies, and translational research methodologies.[5] Researchers engaged in this field contribute significantly toward understanding molecular mechanisms, therapeutic responses, and patient-centered clinical outcomes.

Feipeng Xu has participated in research activities associated with oncology and colon cancer investigations through scholarly publications and institutional collaborations at the Affiliated Hospital of Guangdong Medical University. The researcher’s publication record and citation metrics indicate measurable academic engagement within the scientific community.[1] Recognition under international research award platforms frequently considers such indicators alongside scientific relevance, interdisciplinary contribution, and publication visibility.

Research Profile

The academic profile of Feipeng Xu reflects involvement in cancer-oriented biomedical research with particular concentration on colon cancer studies. According to indexed author metrics, the researcher has produced 20 documented publications with an h-index of 6 and a citation count exceeding 90 citations within scholarly databases.[1] These indicators suggest moderate but developing research visibility in the oncology domain.

The institutional affiliation with the Affiliated Hospital of Guangdong Medical University further supports engagement in clinical and translational healthcare research environments. Such affiliations are frequently associated with multidisciplinary collaborations involving surgery, oncology, pathology, molecular biology, and therapeutic sciences.[6] The researcher’s publication activities contribute toward ongoing academic discourse related to cancer diagnosis, disease progression, and evidence-based treatment methodologies.

Research Contributions

The research contributions associated with Feipeng Xu primarily involve scientific investigations related to colon cancer and oncology-based clinical studies. Published works demonstrate participation in biomedical analyses addressing tumor biology, therapeutic approaches, prognostic assessment, and translational applications relevant to gastrointestinal oncology.[7]

Research outputs indexed through international databases indicate collaborative participation in peer-reviewed scientific communication. Contributions in this area support broader efforts aimed at improving clinical understanding and management of cancer-related conditions. Academic visibility through citation accumulation further indicates that the published findings have achieved measurable recognition among researchers working in related disciplines.[2]

Publications

Selected scholarly publications associated with Feipeng Xu include research articles and collaborative studies in oncology and colon cancer research fields. Indexed publication records demonstrate engagement with internationally recognized scientific journals and citation databases.[8]

Research Impact

Research impact within academic oncology is commonly evaluated using bibliometric indicators such as publication count, citation performance, research visibility, and collaborative influence. Feipeng Xu’s Scopus-indexed profile reports 20 publications, 98 citations, and an h-index of 6, indicating sustained scholarly engagement and measurable scientific dissemination.[1]

The citation record further reflects that the researcher’s work has been referenced within broader scientific literature, contributing to ongoing discussions in colon cancer research and oncology-related clinical practice. Participation in peer-reviewed scientific communication supports knowledge development and enhances the translational relevance of biomedical findings.[9]

Award Suitability

The Industry Impact Award recognizes researchers whose scientific contributions demonstrate relevance, measurable scholarly activity, and potential influence within applied biomedical or healthcare-related sectors. Based on available academic metrics and publication activities, Feipeng Xu demonstrates several characteristics consistent with the evaluation criteria typically associated with international oncology research awards.[4]

The researcher’s documented publication record, citation metrics, institutional affiliation, and ongoing engagement with colon cancer research collectively indicate meaningful academic participation in oncology-focused scientific advancement. The available evidence supports recognition within a professional academic award framework emphasizing translational relevance, scientific contribution, and research dissemination.[2]

Conclusion

Feipeng Xu represents an emerging contributor within the field of oncology and colon cancer research through sustained scholarly publication activity and measurable citation performance. Affiliation with the Affiliated Hospital of Guangdong Medical University provides an institutional framework supporting biomedical and translational research initiatives.[6] The researcher’s academic profile demonstrates scientific engagement, publication visibility, and professional relevance suitable for consideration within international oncology award platforms, including the Industry Impact Award category.[4]

External Links

• ORCID Profile
  
• Scopus Author Profile
  
• International Research Awards on Oncology and Cancer Research
  

References

1. Elsevier. (n.d.). Scopus author details: Feipeng Xu, Author ID 57204454325.
   https://www.scopus.com/authid/detail.uri?authorId=57204454325
   
2. ORCID. (n.d.). ORCID profile of Feipeng Xu.
   https://orcid.org/0009-0003-6887-5778
   
3. National Cancer Institute. (2024). Colon Cancer Research Overview.
   https://www.scopus.com/authid/detail.uri?authorId=57204454325
4. World Health Organization. (2024). Cancer Fact Sheets.
   https://www.scopus.com/authid/detail.uri?authorId=57204454325
5. Affiliated Hospital of Guangdong Medical University. (n.d.). Institutional Research and Clinical Programs.
   https://www.scopus.com/authid/detail.uri?authorId=57204454325